Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin...

Area of Science:

• Microbiology
• Infectious Diseases
• Bacterial Pathogenesis

Background:

• Staphylococcus aureus infections are a major global health threat, exacerbated by rising antibiotic resistance.
• S. aureus possesses bacterial nitric-oxide synthase (bNOS), enabling nitric oxide (NO) production from L-arginine.
• Understanding bNOS's role is crucial for developing new therapeutic strategies against MRSA.

Purpose of the Study:

• To investigate the contribution of bNOS to the virulence and antibiotic susceptibility of methicillin-resistant S. aureus (MRSA).
• To generate and characterize a bNOS-deficient MRSA mutant in the USA300 clone.

Main Methods:

• Construction of an isogenic bNOS-deficient MRSA USA300 mutant.
• Assessment of MRSA susceptibility to reactive oxygen species, antimicrobial peptides, and human neutrophils.
• Evaluation of MRSA resistance to pharmaceutical antibiotics (vancomycin, daptomycin, aminoglycosides).
• Analysis of MRSA virulence in a mouse subcutaneous infection model.

Main Results:

• Loss of bNOS increased MRSA susceptibility to reactive oxygen species, cathelicidin antimicrobial peptides, and neutrophil-mediated killing.
• bNOS deficiency enhanced MRSA resistance to vancomycin and daptomycin but conferred susceptibility to aminoglycosides.
• The bNOS mutant exhibited reduced virulence, evidenced by decreased survival and smaller abscesses in mice.

Conclusions:

• bNOS plays a significant role in MRSA's resistance to innate immune defenses and certain antibiotics.
• bNOS contributes to MRSA virulence and pathogenesis.
• Targeting bNOS could be a promising strategy to combat MRSA infections by reducing virulence and enhancing antibiotic efficacy.